OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Kevin Zhou's Sam Altman, published in November 2024, is a detailed portrait of the AI entrepreneur, from his early days as a ... ended up taking part. The biography offers contradictory views ...
OpenAI chief executive Sam Altman, who provided the initial $180mn ... which will be tested in an early stage study in Australia this year. It is also working on drugs for rejuvenating blood ...
OpenAI chief Sam Altman has ... It's not the first time Altman and Musk have publicly sparred with each other online. The pair have a history that goes back to OpenAI's early days.
Sam Altman, CEO of OpenAI, has clarified that the company has not yet achieved Artificial General Intelligence (AGI), despite ...
The race to increase human life span through ... that’s set to enter an early-stage trial in Australia this year. Some of the investment will come from OpenAI CEO Sam Altman, who also provided ...